S. Torrisi (Acireale (CT), Italy), S. Vanoni (Córdoba, Argentina)
Correlation between physical activity and prognostic markers in patients with idiopathic pulmonary fibrosis M. Oguz (Istanbul, Turkey), Z. Kaya (Istanbul, Turkey), B. Akinci (Istanbul, Turkey), G. Kuran Arslan (Istanbul, Turkey), G. Okumus (Istanbul, Turkey)
| |
Methylprednisolone pulse therapy in Acute Exacerbations of Idiopathic Pulmonary Fibrosis P. Mari (Roma (RM), Italy), M. Siciliano (Roma (RM), Italy), F. Cefaloni (Roma (RM), Italy), S. Cortese (Roma (RM), Italy), E. Schiavi (Roma (RM), Italy), B. Iovene (Roma (RM), Italy), G. Sgalla (Roma (RM), Italy), G. Corbo (Roma (RM), Italy), F. Varone (Roma (RM), Italy), L. Richeldi (Roma (RM), Italy)
| |
Severity before or at the onset of acute exacerbation (AE) can predict the long-term and short-term survival of AE in idiopathic interstitial pneumonias (IIPs)? T. Arai (Sakai, Japan), S. Shintani (Sakai, Japan), C. Sugimoto (Sakai, Japan), N. Takeuchi (Sakai, Japan), T. Kagawa (Sakai, Japan), Y. Inoue (Sakai, Japan), K. Tachibana (Sakai, Japan), M. Akira (Sakai, Japan), Y. Inoue (Sakai, Japan)
| |
RELATIONSHIP BETWEEN AIR POLLUTION IN MADRID AND THE MORTALITY OF IDIOPATHIC PULMONARY FIBROSIS P. Mariscal Aguilar (Madrid, Spain), L. Gómez Carrera (Madrid, Spain), E. Zamarrón De Lucas (Madrid, Spain), J. Padilla Brito (Madrid, Spain), M. Hidalgo Sánchez (Madrid, Spain), M. Torres Sánchez (Madrid, Spain), G. Bonilla Hernán (Madrid, Spain), M. Fernández-Velilla Peña (Madrid, Spain), P. Díaz-Agero Álvarez (Madrid, Spain), E. Villamañán Bueno (Madrid, Spain), R. Regojo Zapata (Madrid, Spain), C. Prados Sánchez (Madrid, Spain), C. Carpio Segura (Madrid, Spain), R. Alvarez-Sala Walther (Madrid, Spain)
| |
Handigrip strenght and dynapenia in patients with idiopathic pulmonary fibrosis (IPF) l. capitelli (Naples, Italy), A. Stanziola (Naples, Italy), A. Di Gregorio (Naples, Italy), L. Gallotti (Naples, Italy), F. De Blasio (Naples, Italy), P. Alicante (Naples, Italy), A. Sanduzzi Zamparelli (Naples, Italy), L. Scalfi (Naples, Italy), M. Bocchino (Naples, Italy)
| |
Body composition and prolonged hypoxia in interstitial lung disease patients M. Quintero Martinez (Ciudad De México , Mexico), D. Gonzalez Islas (Ciudad De México , Mexico), A. Orea Tejeda (Ciudad De México , Mexico), V. Martínez Vázquez (Ciudad De México , Mexico), I. Pérez García (Ciudad De México , Mexico), N. Martínez Luna (Ciudad De México , Mexico), O. Martínez Reyna (Ciudad De México , Mexico), L. Verdeja Vendrell (Ciudad De México , Mexico), Y. Gastelum Ayala (Ciudad De México , Mexico), A. Sandoval Sánchez (Ciudad De México , Mexico), M. Gomez Martinez (Ciudad De México , Mexico), R. Sanchez Santillan (Ciudad De México , Mexico), I. Buendía Roldan (Ciudad De México , Mexico), R. Robles Hernandez (Ciudad De México , Mexico), M. Mejia Avila (Ciudad De México , Mexico)
| |
Serum CC16 is a potential predictor for IPF diagnosis and prognosis Y. Tian (Nanjing, China), X. Gui (Nanjing, China), H. Li (Nanjing, China), J. Ding (Nanjing, China), Y. Liu (Nanjing, China), Y. Wang (Nanjing, China), J. Dai (Nanjing, China), H. Cai (Nanjing, China)
| |
Potential new biomarkers for idiopathic pulmonary fibrosis M. Roksandic Milenkovic (Belgrade, Republic of Serbia), J. Kotur Stevuljevic (Belgrade, Republic of Serbia), V. Ceriman (Belgrade, Republic of Serbia), V. Milenkovic (Belgrade, Republic of Serbia), D. Jovanovic (Belgrade, Republic of Serbia)
| |
IL-18 binding protein as a noble biomarker for idiopathic pulmonary fibrosis Y. Nakanisihi (Hiroshima, Japan), Y. Horimasu (Hiroshima, Japan), K. Yamaguchi (Hiroshima, Japan), S. Sakamoto (Hiroshima, Japan), T. Masuda (Hiroshima, Japan), T. Nakashima (Hiroshima, Japan), S. Miyamoto (Hiroshima, Japan), H. Iwamoto (Hiroshima, Japan), K. Fujitaka (Hiroshima, Japan), H. Hamada (Hiroshima, Japan), N. Hattori (Hiroshima, Japan)
| |
Immunologically 'supercharged' monocytes as drivers of chronic fibrosis in idiopathic pulmonary fibrosis E. Fraser (Oxford (Oxfordshire), United Kingdom), L. Denney (Oxford, United Kingdom), C. Vuppusetty (Oxford, United Kingdom), A. Antanaviciute (Oxford, United Kingdom), V. St.Noble (Oxford, United Kingdom), R. Benamore (Oxford, United Kingdom), R. Hoyles (Oxford, United Kingdom), L. Ho (Oxford (Oxfordshire), United Kingdom)
| |
KL-6 as a potential therapeutic biomarker in fibrosing interstitial lung diseases V. Somogyi (Heidelberg, Germany), K. Mayer (Heidelberg, Germany), K. Kriegsmann (Heidelberg, Germany), M. Kriegsmann (Heidelberg, Germany), P. Findeisen (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany)
| |
Endotrophin is related to disease progression in idiopathic pulmonary fibrosis H. Jessen (Herlev, Denmark), N. Hoyer (Copenhagen, Denmark), S. Rønnow (Herlev, Denmark), M. Karsdal (Herlev, Denmark), D. Leeming (Herlev, Denmark), J. Sand (Herlev, Denmark), S. Shaker (Copenhagen, Denmark)
| |
Serum ST2 in Idiopathic Pulmonary Fibrosis (IPF): a possible new biomarker of disease? F. Cavalli (Roma (RM), Italy), E. Puxeddu (Roma (RM), Italy), G. Cillis (Roma (RM), Italy), E. Teodori (Roma (RM), Italy), M. Perrone (Roma (RM), Italy), P. Rogliani (Roma (RM), Italy)
| |
Neutrophil-to-lymphocyte ratio in IPF patients: a novel prognostic biomarker? . d'Alessandro (Siena, Italy), L. Bergantini (Siena, Italy), P. Cameli (Siena, Italy), A. Carleo (Hannover, Germany), P. Sestini (Siena, Italy), E. Bargagli (Siena, Italy)
| |
Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion A. Yamagata (Okayama, Japan), M. Arita (Okayama, Japan), F. Tokioka (Okayama, Japan), C. Sugimoto (Osaka, Japan), H. Sumikawa (Osaka, Japan), T. Tanaka (Hyogo, Japan), H. Yasui (Shizuoka, Japan), T. Fujisawa (Shizuoka, Japan), Y. Nakamura (Shizuoka, Japan), T. Suda (Shizuoka, Japan), T. Ishida (Okayama, Japan)
| |
Cytokines, chemokines and growth factors concentration in BAL fluid from patients with Idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP) M. Kaestle (Biberach an der Riß, Germany), K. Geillinger-Kästle (Biberach an der Riß, Germany), D. Lamb (Biberach an der Riß, Germany), U. Costabel (Essen, Germany), D. Theegarten (Essen, Germany), S. Uddin (Biberach an der Riß, Germany), M. Thomas (Biberach an der Riß, Germany), L. Wollin (Biberach an der Riß, Germany), F. Bonella (Essen, Germany)
| |
Difference between pathogenic and inhibitory bacterial florae is associated with acute exacerbation of idiopathic pulmonary fibrosis S. Ohshimo (Hiroshima, Japan), H. Nishi (Hiroshima, Japan), K. Yamaguchi (Hiroshima, Japan), Y. Horimasu (Hiroshima, Japan), T. Masuda (Hiroshima, Japan), S. Miyamoto (Hiroshima, Japan), H. Iwamoto (Hiroshima, Japan), K. Fujitaka (Hiroshima, Japan), H. Hamada (Hiroshima, Japan), H. Kawaguchi (Hiroshima, Japan), F. Bonella (Essen, Germany), J. Guzman (Bochum, Germany), U. Costabel (Essen, Germany), N. Hattori (Hiroshima, Japan), N. Shime (Hiroshima, Japan)
| |
Analysis of the ratio of the main pulmonary artery to that of the aorta on chest CT in patients with combined pulmonary fibrosis and emphysema. T. Hirouchi (Tokyo, Japan), S. Ota (Tokyo, Japan), M. Nishimura (Tokyo, Japan), K. Shinada (Tokyo, Japan), M. Morikawa (Tokyo, Japan), S. Yamanaka (Tokyo, Japan), M. Shinoda (Tokyo, Japan), O. Sasaki (Tokyo, Japan), M. Shinkai (Tokyo, Japan)
| |
Angiogenesis in idiopathic pulmonary fibrosis G. Juan Samper (Valencia, Spain), C. Sabater Abad (Valencia, Spain), S. Torres Martinez (Valencia, Spain), E. Fernández-Fabrellas (Valencia, Spain), V. Jaimes Diaz (Valencia, Spain), E. Verdejo Mengual (Valencia, Spain), S. Calabuig Fariñas (Valencia, Spain)
| |